| The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. | |
| | |
MedLine Citation:
|
PMID: 8903369 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We examined changes in the hypervariable region 1 of the hepatitis C virus (HCV) RNA that occurred with interferon therapy in 33 patients with chronic hepatitis C to assess the clinical significance of this region. The 33 patients had HCV genotype 1b and were classified into three groups based on serum aminotransferase levels during and after therapy with alpha interferon; long-term responders (n = 9), short-term responders (n = 11), and nonresponders (n = 13). Changes in the genetic heterogeneity of the hypervariable region 1 were determined by using nonisotopic polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). HCV RNA levels were evaluated by reverse transcriptase PCR and branched DNA probe assays. Changes in sequences were determined by cloning and sequencing analysis. Before therapy, the long-term responders had significantly lower degrees of heterogeneity and lower viral levels than nonresponders. There were no significant differences between short-term and nonresponders. With interferon therapy, viral levels and degree of heterogeneity decreased to a greater extent among long-term and short-term responders than among nonresponders. Sequencing analysis showed that the three groups had similar clone numbers initially, but long-term responders had rather homogeneous viral populations, whereas short-term and nonresponders had heterogeneous populations, but that there were no nucleotide sequences or amino acid alignments that were specific for any group before, during, and 6 months after therapy. Approximately half of short-term and nonresponders received a second course of interferon 7 to 10 months after the initial therapy; all showed an identical response to the second course of therapy regardless of interim changes in the heterogeneity of hypervariable region 1. These findings suggest that (1) patients who were nonresponders or short-term responders had mixed viral populations that had differing sensitivities to interferon, (2) the changes in the hypervariable region 1 (HVR 1) did not affect responsiveness to interferon, and (3) the lower heterogeneity in the HVR 1 was associated with a long-term response to interferon only when the viral levels were low. |
| | |
Authors:
|
M Shindo; K Hamada; S Koya; K Arai; Y Sokawa; T Okuno |
Related Documents
:
|
11585099 - Treatment of viral hepatitis--2001. 11282149 - Multifocal motor neuropathy. 11771729 - Treatment of chronic viral hepatitis. 7908719 - Treatment of refractory disseminated nontuberculous mycobacterial infection with interf... 12707469 - Purpura with cold urticaria in a patient with hepatitis c virus infection-associated mi... 9322499 - A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation ... 11470029 - Therapy and prevention of cytomegalovirus retinitis. 20044459 - Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, hiv and c... 20585339 - Evolving challenges in hepatic fibrosis. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Hepatology (Baltimore, Md.) Volume: 24 ISSN: 0270-9139 ISO Abbreviation: Hepatology Publication Date: 1996 Nov |
Date Detail:
|
Created Date: 1996-12-12 Completed Date: 1996-12-12 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 8302946 Medline TA: Hepatology Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1018-23 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine, Akashi Municipal Hospital, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chronic Disease Female Genetic Variation Genome, Viral Hepacivirus / genetics* Hepatitis C / therapy*, virology Humans Interferon-alpha / therapeutic use* Male Middle Aged Polymorphism, Single-Stranded Conformational RNA, Viral / analysis* |
| Chemical | |
Reg. No./Substance:
|
0/Interferon-alpha; 0/RNA, Viral |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents.
Next Document: Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cel...